Key points are not available for this paper at this time.
This protocol has been used to generate a single cell suspension from tumor tissue for use in single cell analysis. It has been optimized to eliminate dead cells that may be present after cancer therapy and which can compromise single-cell RNAseq and other assays that require a high proportion of live cells.
Berube et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: